Skip to main content
. 2018 Apr 17;22(7):3526–3536. doi: 10.1111/jcmm.13629

Figure 8.

Figure 8

Proposed models on the inhibitory role of miR‐1‐3p/miR‐206 in HGF‐induced gefitinib resistance. As depicted in the model, miR‐1‐3p/miR‐206 overcome HGF‐induced gefitinib resistance by targeting c‐Met‐Akt/Erk pathway and epithelial‐mesenchymal transition (EMT) in lung cancer with EGFR activating mutation